Racial/Ethnic Minorities Have Higher Risk of Familial-Associated Early-Onset Cancer
The study showed differences by cancer type and race/ethnicity.
Lung Cancer
Reduced-Dose CT Comparable to Standard CT for Detecting Lung Nodules in Younger Patients
Researchers sought to determine the effectiveness of reduced-dose CT for detection and monitoring of lung nodules in pediatric and young adult patients.
Less Than Half of NSCLC Patients Received Comprehensive Biomarker Testing in a Real-World Study
Most patients had at least 1 biomarker test, but only 46% had all 5 biomarker tests.
Survival Increased for Multiple Cancer Types for Teens, Young Adults
For adolescents and young adult patients with cancer diagnosed at age 15 to 39 years, there has been improvement in five-year relative survival for multiple cancer types.
Study Suggests Possible Fix for Gender Disparity in the 2021 US Preventative Services Task Force Guidelines
Adding PLCOm2012 criteria to 2021 USPSTF guidelines could increase lung cancer screening in women.
Smoking History May Predict Immune Checkpoint Inhibitor Outcomes in Metastatic Non-Small Cell Lung Cancer
A detailed smoking history may help to inform patient outcomes.
Pembrolizumab Provides Durable Survival Benefit in Metastatic Non-Small Cell Lung Cancer With High PD-L1 Expression
The 5-year survival rate was superior with pembrolizumab.
Overview of Dosing, Administration, Side-Effect Management of Sotorasib for NSCLC With KRAS G12C Mutation
Dosing, administration, and nurse management of potential side effects of this first-in-class medication are reviewed.
Savolitinib May Be Effective in Treating Pulmonary Sarcomatoid Carcinoma
Researchers assessed the safety of savolitinib in patients with pulmonary sarcomatoid carcinoma and other NSCLC subtypes positive for METex14-positive.
Adding Ipilimumab to Nivolumab No Better in Pretreated Squamous NSCLC
For patients with advanced, chemotherapy-pretreated, immune checkpoint inhibitor-naive Sq NSCLC, ipilimumab added to nivolumab does not improve outcomes versus nivolumab alone.
- Loading...
Loading...
Next post in Lung Cancer
Loading... 
Loading...